JTZ-951

· Akros Pharma Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for JTZ-951, covering 2014-03-18 to 2021-03-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Efficacy and Safety of JTZ-951 Compared to Darbepoetin Alfa in Korean Renal Anemia Patients Receiving Hemodialysis. [Phase 3]

See pricing